miR-9 inhibits the metastatic ability of hepatocellular carcinoma via targeting beta galactoside alpha-2,6-sialyltransferase 1
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-9 inhibits the metastatic ability of hepatocellular carcinoma via targeting beta galactoside alpha-2,6-sialyltransferase 1
Authors
Keywords
miR-9, St6gal1, Hepatocellular carcinoma, Metastasis, Glycosylation
Journal
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-07-13
DOI
10.1007/s13105-018-0642-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA-30a suppresses autophagy-mediated anoikis resistance and metastasis in hepatocellular carcinoma
- (2018) Xiu-Tao Fu et al. CANCER LETTERS
- Sialylation of EGFR by the ST6Gal-I sialyltransferase promotes EGFR activation and resistance to gefitinib-mediated cell death
- (2018) Colleen M. Britain et al. Journal of Ovarian Research
- Up-regulation of sialyltransferases increases lymphatic metastasis in pancreatic cancer via the integrin-mediated pathway
- (2017) Wen-Chun Hung et al. PANCREATOLOGY
- MiRNA-203 suppresses cell proliferation, migration and invasion in colorectal cancer via targeting of EIF5A2
- (2016) Biao Deng et al. Scientific Reports
- miR-9-3p plays a tumour-suppressor role by targeting TAZ (WWTR1) in hepatocellular carcinoma cells
- (2015) T Higashi et al. BRITISH JOURNAL OF CANCER
- Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance
- (2015) Laetitia Seguin et al. TRENDS IN CELL BIOLOGY
- MicroRNA-134 suppresses endometrial cancer stem cells by targeting POGLUT1 and Notch pathway proteins
- (2014) Yongtao Gao et al. FEBS LETTERS
- Let-7c inhibits metastatic ability of mouse hepatocarcinoma cells via targeting mannoside acetylglucosaminyltransferase 4 isoenzyme A
- (2014) Yanjie Guo et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Mannose-mediated inhibitory effects of PA-MSHA on invasion and metastasis of hepatocellular carcinoma via EGFR/Akt/IκBβ/NF-κB pathway
- (2014) Tao Li et al. LIVER INTERNATIONAL
- Expression of MicroRNA-15b and the Glycosyltransferase GCNT3 Correlates with Antitumor Efficacy of Rosemary Diterpenes in Colon and Pancreatic Cancer
- (2014) Margarita González-Vallinas et al. PLoS One
- Increasing the α 2, 6 Sialylation of Glycoproteins May Contribute to Metastatic Spread and Therapeutic Resistance in Colorectal Cancer
- (2013) Jung-Jin Park et al. Gut and Liver
- Modification of Sialylation Mediates the Invasive Properties and Chemosensitivity of Human Hepatocellular Carcinoma
- (2013) Yongfu Zhao et al. MOLECULAR & CELLULAR PROTEOMICS
- HMDD v2.0: a database for experimentally supported human microRNA and disease associations
- (2013) Yang Li et al. NUCLEIC ACIDS RESEARCH
- miR-26a enhances miRNA biogenesis by targeting Lin28B and Zcchc11 to suppress tumor growth and metastasis
- (2013) X Fu et al. ONCOGENE
- ST6Gal-I sialyltransferase confers cisplatin resistance in ovarian tumor cells
- (2013) Matthew J Schultz et al. Journal of Ovarian Research
- MiR-34a inhibits lymphatic metastasis potential of mouse hepatoma cells
- (2011) Yanjie Guo et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Inhibition of Focal Adhesion Kinase by PF-562,271 Inhibits the Growth and Metastasis of Pancreatic Cancer Concomitant with Altering the Tumor Microenvironment
- (2011) J. B. Stokes et al. MOLECULAR CANCER THERAPEUTICS
- Biological functions of microRNAs: a review
- (2010) Yong Huang et al. JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- MicroRNA-9 reduces cell invasion and E-cadherin secretion in SK-Hep-1 cell
- (2009) Tan Hao-Xiang et al. MEDICAL ONCOLOGY
- Epigenetic inactivation of microRNA genehsa-mir-9-1in human breast cancer
- (2007) U Lehmann et al. JOURNAL OF PATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started